Postes actifs de Kristen Oberg
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Mycovia Pharmaceuticals, Inc.
 Mycovia Pharmaceuticals, Inc. BiotechnologyHealth Technology Mycovia Pharmaceuticals, Inc. develops novel drugs in areas of unmet medical need, with an initial focus in women?s health. Its product candidate, VT-1161, engages in developed as a treatment for recurrent vulvovaginal candidiasis. The company was founded in 2018 and is headquartered in Durham, NC. | Compliance Officer | - | - |
| Conseiller Juridique Général | - | - |
Historique de carrière de Kristen Oberg
Statistiques
Internationale
| Etats-Unis | 2 |
Opérationnelle
| Compliance Officer | 1 |
| General Counsel | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Mycovia Pharmaceuticals, Inc.
Mycovia Pharmaceuticals, Inc. BiotechnologyHealth Technology Mycovia Pharmaceuticals, Inc. develops novel drugs in areas of unmet medical need, with an initial focus in women?s health. Its product candidate, VT-1161, engages in developed as a treatment for recurrent vulvovaginal candidiasis. The company was founded in 2018 and is headquartered in Durham, NC. | Health Technology |
- Bourse
- Insiders
- Kristen Oberg
- Expérience
